Received: 11 September 2022
Accepted: 2 November 2022
First Online: 16 November 2022
: Murine studies were conducted after IACUC approved protocol. Blood samples were collected from healthy donors with written consent.
: All authors critically reviewed and approved the final manuscript.
: Song Li, Dianze Chen, Dandan Liu, Huiqin Guo, Chunmei Yang, Wei Zhang, Li Zhang, Gui Zhao, Xiaoping Tu, Liang Peng, Sijin Liu, Xing Bai, and Ruliang Zhang are employees in ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. Wenzhi Tian is the founder of ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. Jifeng Yu, Yongping Song, Zhongxing Jiang declared no conflicts of interest.